AR095421A1 - Moduladores de p2x7 - Google Patents
Moduladores de p2x7Info
- Publication number
- AR095421A1 AR095421A1 ARP140100965A ARP140100965A AR095421A1 AR 095421 A1 AR095421 A1 AR 095421A1 AR P140100965 A ARP140100965 A AR P140100965A AR P140100965 A ARP140100965 A AR P140100965A AR 095421 A1 AR095421 A1 AR 095421A1
- Authority
- AR
- Argentina
- Prior art keywords
- pyridinyl
- phenyl
- pyrazizyl
- thiophenyl
- pyrazinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
Abstract
Reivindicación 1: Un compuesto de la fórmula (1) o un enantiómero o diastereómero de este; o una sal farmacéuticamente aceptable de estos; en donde n es un entero de 0 - 1; X es CH₂ cuando n es 0, o X es CH₂ u oxígeno cuando n es 1; R¹ es fenilo o piridinilo, en donde el fenilo o piridinilo se sustituye, opcionalmente, con 1 a 4 sustituyentes seleccionados independientemente de halógeno y alquilo; y R² es fenilo, piridinilo, pirazinilo, piradizinilo, pirimidinilo, pirrolilo, pirazolilo, tiazolilo o tiofenilo, en donde el fenilo, piridinilo, pirazinilo, piradizinilo, pirimidinilo, pirrolilo, pirazolilo, tiazolilo o tiofenilo se sustituye, opcionalmente, con 1 a 2 sustituyentes seleccionados independientemente del grupo que consiste en halógeno, alquilo, hidroxi y alcoxi.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361785558P | 2013-03-14 | 2013-03-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR095421A1 true AR095421A1 (es) | 2015-10-14 |
Family
ID=50631041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP140100965A AR095421A1 (es) | 2013-03-14 | 2014-03-13 | Moduladores de p2x7 |
Country Status (10)
Country | Link |
---|---|
US (3) | US9540388B2 (es) |
EP (2) | EP2970287B1 (es) |
JP (1) | JP6294954B2 (es) |
AR (1) | AR095421A1 (es) |
ES (2) | ES2652648T3 (es) |
HK (2) | HK1218649A1 (es) |
JO (1) | JO3509B1 (es) |
TW (1) | TWI627174B (es) |
UY (1) | UY35447A (es) |
WO (1) | WO2014152621A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014152537A1 (en) | 2013-03-14 | 2014-09-25 | Janssen Pharmaceutica Nv | P2x7 modulators |
EP2970271B1 (en) | 2013-03-14 | 2017-11-08 | Janssen Pharmaceutica NV | P2x7 modulators |
TWI627174B (zh) | 2013-03-14 | 2018-06-21 | 比利時商健生藥品公司 | P2x7調控劑 |
JO3773B1 (ar) | 2013-03-14 | 2021-01-31 | Janssen Pharmaceutica Nv | معدلات p2x7 |
ES2714048T3 (es) * | 2014-09-12 | 2019-05-24 | Janssen Pharmaceutica Nv | Moduladores de P2X7 |
JP6358639B2 (ja) | 2015-04-24 | 2018-07-18 | 塩野義製薬株式会社 | 6員複素環誘導体およびそれらを含有する医薬組成物 |
JP6736660B2 (ja) * | 2015-09-04 | 2020-08-05 | ヤンセン ファーマシューティカ エヌ.ベー. | 疼痛のための治療化合物及びその合成 |
CN105596301A (zh) * | 2016-01-29 | 2016-05-25 | 中国药科大学 | 一种以异喹啉为基本骨架的p2x7受体拮抗剂的纳米混悬剂及其制备方法 |
CN105503884B (zh) * | 2016-02-17 | 2017-10-13 | 上海皓元生物医药科技有限公司 | 一种用于合成bet蛋白抑制剂的关键中间体的合成方法 |
MX2019004107A (es) * | 2016-10-17 | 2019-08-05 | Shionogi & Co | Derivado heterociclico nitrogenado biciclico y composicion farmaceutica que lo contiene. |
EP3856179A1 (en) | 2018-09-28 | 2021-08-04 | Janssen Pharmaceutica N.V. | Monoacylglycerol lipase modulators |
EP3856178A1 (en) | 2018-09-28 | 2021-08-04 | Janssen Pharmaceutica NV | Monoacylglycerol lipase modulators |
EP3962493A2 (en) | 2019-05-03 | 2022-03-09 | Flagship Pioneering Innovations V, Inc. | Methods of modulating immune activity/level of irf or sting or of treating cancer, comprising the administration of a sting modulator and/or purinergic receptor modulator or postcellular signaling factor |
US11839663B2 (en) | 2019-09-30 | 2023-12-12 | Janssen Pharmaceutica Nv | Radiolabelled MGL pet ligands |
JP2023518511A (ja) | 2020-03-26 | 2023-05-01 | ヤンセン ファーマシューティカ エヌ.ベー. | モノアシルグリセロールリパーゼ調節因子 |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US905687A (en) | 1908-07-14 | 1908-12-01 | Samuel W Evans Jr | Folding umbrella and cane. |
US4816463A (en) | 1986-04-01 | 1989-03-28 | Warner-Lambert Company | Substituted diimidazo [1,5-a: 4',5'-d]pyridines having antihypertensive activity |
US4812462A (en) | 1986-04-01 | 1989-03-14 | Warner-Lambert Company | 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity |
EP0551432A1 (en) | 1990-10-02 | 1993-07-21 | Warner-Lambert Company | 4,5,6,7-tetrahydro-1h-imidazo 4,5-c]pyridine derivatives and analogues as angiotensin ii receptor antagonists |
US6818643B1 (en) | 1999-12-08 | 2004-11-16 | Bristol-Myers Squibb Company | Neurotrophic bicyclic diamides |
US20060100233A1 (en) | 2002-07-25 | 2006-05-11 | Manuela Villa | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
GB0312609D0 (en) | 2003-06-02 | 2003-07-09 | Astrazeneca Ab | Novel compounds |
AR045037A1 (es) | 2003-07-10 | 2005-10-12 | Aventis Pharma Sa | Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion. |
CA2576465A1 (en) | 2004-08-23 | 2006-03-02 | Merck & Co., Inc. | Fused triazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
EP1844003A4 (en) | 2005-01-27 | 2010-09-22 | Astrazeneca Ab | NEW BIAROMATIC COMPOUNDS AS INHIBITORS OF THE P2X7 RECEPTOR |
US7402596B2 (en) | 2005-03-24 | 2008-07-22 | Renovis, Inc. | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
WO2006110516A1 (en) | 2005-04-11 | 2006-10-19 | Abbott Laboratories | Acylhydrazide p2x7 antagonists and uses thereof |
US7943617B2 (en) | 2006-11-27 | 2011-05-17 | Bristol-Myers Squibb Company | Heterobicyclic compounds useful as kinase inhibitors |
AU2008269177A1 (en) | 2007-06-21 | 2008-12-31 | Schering Corporation | Polycyclic Guanine Derivatives and use thereof |
EA020332B1 (ru) | 2007-08-10 | 2014-10-30 | Х. Лундбекк А/С | Аналоги гетероариламидов |
FR2921342B1 (fr) | 2007-09-20 | 2010-03-12 | Airbus France | Carenage aerodynamique arriere inferieur pour dispositif d'accrochage d'un moteur d'aeronef |
KR101598397B1 (ko) | 2008-04-22 | 2016-02-29 | 얀센 파마슈티카 엔.브이. | 퀴놀린 또는 이소퀴놀린 치환된 피2엑스7 안타고니스트 |
WO2010060854A1 (en) | 2008-11-25 | 2010-06-03 | Nerviano Medical Sciences S.R.L. | Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents |
WO2010066629A2 (en) | 2008-12-09 | 2010-06-17 | F. Hoffmann-La Roche Ag | Novel azaindoles |
JP5654001B2 (ja) * | 2009-04-29 | 2015-01-14 | グラクソ グループ リミテッドGlaxo Group Limited | P2X7調節因子としての5,6,7,8−テトラヒドロ[1,2,4]トリアゾロ[4,3−a]ピラジン誘導体 |
GB0907515D0 (en) | 2009-04-30 | 2009-06-10 | Glaxo Group Ltd | Compounds |
US8871760B2 (en) | 2009-09-21 | 2014-10-28 | Roche Palo Alto Llc | [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators |
BR112012025101B1 (pt) | 2010-04-02 | 2021-08-31 | Ogeda S.A. | Compostos antagonistas seletivos de receptor nk-3, composição farmacêutica e medicamento compreendendo os mesmos |
EP2558661A4 (en) | 2010-04-16 | 2014-10-29 | Fernandez Rodrigo Graf | FOLDABLE STRUCTURES FOR CONSTRUCTION |
EP2619204A4 (en) | 2010-09-21 | 2014-08-27 | Merck Sharp & Dohme | TRIAZOLOPYRAZINONES AS ANTAGONISTS OF P2X7 RECEPTORS |
MX2014014234A (es) | 2012-05-22 | 2015-05-07 | Genentech Inc | Benzamidas n-sustituidas y su uso en el tratamiento del dolor. |
US8859774B2 (en) | 2012-05-25 | 2014-10-14 | Corcept Therapeutics, Inc. | Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators |
JO3459B1 (ar) | 2012-09-09 | 2020-07-05 | H Lundbeck As | تركيبات صيدلانية لعلاج مرض الزهايمر |
TWI588131B (zh) | 2012-10-15 | 2017-06-21 | 雅酶股份有限公司 | 經取代苯化合物 |
PE20150778A1 (es) | 2012-10-16 | 2015-05-23 | Janssen Pharmaceutica Nv | Moduladores de quinolinilo unidos a metileno de ror-gamma-t |
MX2015005428A (es) | 2012-11-01 | 2015-07-21 | Incyte Corp | Derivados triciclicos fusionados de tiofeno como inhibidores de la cinasa janus (jak). |
US9796729B2 (en) | 2012-11-23 | 2017-10-24 | Glaxosmithkline Llc | Compounds as diacylglycerol acyltransferase inhibitors |
ES2718495T3 (es) | 2012-12-21 | 2019-07-02 | Celgene Quanticel Res Inc | Inhibidores de la histona desmetilasa |
US9233974B2 (en) | 2012-12-21 | 2016-01-12 | Gilead Sciences, Inc. | Antiviral compounds |
KR102212923B1 (ko) | 2012-12-21 | 2021-02-04 | 플렉시콘 인코퍼레이티드 | 키나제 조절을 위한 화합물 및 방법, 및 그에 대한 적응증 |
KR20150119012A (ko) | 2013-02-08 | 2015-10-23 | 셀진 아빌로믹스 리서치, 인코포레이티드 | Erk 억제제 및 이의 용도 |
NO335177B1 (no) | 2013-03-06 | 2014-10-13 | Cambi Technology As | Fremgangsmåte og anordning for termisk biologisk nedbryting og avvanning av biomasse |
UY35370A (es) | 2013-03-06 | 2014-09-30 | Janssen Pharmaceutica Nv | Moduladores benzoimidazol-2-il pirimidina del receptor de histamina h4 |
CA2901537C (en) | 2013-03-14 | 2021-09-07 | Glaxosmithkline Intellectual Property (No.2) Limited | 2,3-disubstituted 1- acyl-4-amino-1 ,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors |
US9242969B2 (en) | 2013-03-14 | 2016-01-26 | Novartis Ag | Biaryl amide compounds as kinase inhibitors |
JO3383B1 (ar) | 2013-03-14 | 2019-03-13 | Lilly Co Eli | مثبطات cdc7 |
EP3366678A1 (en) | 2013-03-14 | 2018-08-29 | Newlink Genetics Corporation | Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization |
EP2970271B1 (en) | 2013-03-14 | 2017-11-08 | Janssen Pharmaceutica NV | P2x7 modulators |
TWI627174B (zh) | 2013-03-14 | 2018-06-21 | 比利時商健生藥品公司 | P2x7調控劑 |
NZ710034A (en) | 2013-03-14 | 2020-06-26 | Boehringer Ingelheim Int | Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c |
HUE039473T2 (hu) | 2013-03-14 | 2019-01-28 | Curadev Pharma Private Ltd | Kinurenin útvonal inhibitorok |
WO2014152537A1 (en) | 2013-03-14 | 2014-09-25 | Janssen Pharmaceutica Nv | P2x7 modulators |
JO3773B1 (ar) | 2013-03-14 | 2021-01-31 | Janssen Pharmaceutica Nv | معدلات p2x7 |
EP2989103B1 (en) | 2013-03-29 | 2019-02-20 | Ogeda Sa | N-acyl-(3-substituted)-(8-methyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective nk-3 receptor antagonists, pharmaceutical composition, methods for use in nk-3 receptor-mediated disorders |
US20180118749A1 (en) | 2014-09-12 | 2018-05-03 | Janssen Pharmaceutica Nv | P2x7 modulators |
ES2714048T3 (es) | 2014-09-12 | 2019-05-24 | Janssen Pharmaceutica Nv | Moduladores de P2X7 |
-
2014
- 2014-03-12 TW TW103108580A patent/TWI627174B/zh not_active IP Right Cessation
- 2014-03-12 JO JOP/2014/0096A patent/JO3509B1/ar active
- 2014-03-13 AR ARP140100965A patent/AR095421A1/es unknown
- 2014-03-14 US US14/775,436 patent/US9540388B2/en active Active
- 2014-03-14 EP EP14721097.5A patent/EP2970287B1/en not_active Not-in-force
- 2014-03-14 EP EP17199037.7A patent/EP3309161B1/en active Active
- 2014-03-14 JP JP2016502474A patent/JP6294954B2/ja not_active Expired - Fee Related
- 2014-03-14 US US14/212,808 patent/US9102686B2/en not_active Expired - Fee Related
- 2014-03-14 ES ES14721097.5T patent/ES2652648T3/es active Active
- 2014-03-14 ES ES17199037T patent/ES2776654T3/es active Active
- 2014-03-14 WO PCT/US2014/027540 patent/WO2014152621A1/en active Application Filing
- 2014-03-14 UY UY0001035447A patent/UY35447A/es unknown
-
2016
- 2016-06-08 HK HK16106617.2A patent/HK1218649A1/zh not_active IP Right Cessation
- 2016-12-12 US US15/375,774 patent/US10053462B2/en not_active Expired - Fee Related
-
2018
- 2018-10-15 HK HK18113181.2A patent/HK1254111A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
TW201522339A (zh) | 2015-06-16 |
TWI627174B (zh) | 2018-06-21 |
WO2014152621A1 (en) | 2014-09-25 |
ES2652648T3 (es) | 2018-02-05 |
US10053462B2 (en) | 2018-08-21 |
JO3509B1 (ar) | 2020-07-05 |
HK1218649A1 (zh) | 2017-03-03 |
EP3309161B1 (en) | 2019-12-18 |
US9540388B2 (en) | 2017-01-10 |
US20170088550A1 (en) | 2017-03-30 |
US9102686B2 (en) | 2015-08-11 |
EP2970287B1 (en) | 2017-11-01 |
UY35447A (es) | 2014-09-30 |
EP3309161A1 (en) | 2018-04-18 |
ES2776654T3 (es) | 2020-07-31 |
HK1254111A1 (zh) | 2019-07-12 |
US20160039836A1 (en) | 2016-02-11 |
EP2970287A1 (en) | 2016-01-20 |
JP2016513702A (ja) | 2016-05-16 |
US20140275056A1 (en) | 2014-09-18 |
JP6294954B2 (ja) | 2018-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR095421A1 (es) | Moduladores de p2x7 | |
AR101815A1 (es) | Compuestos y composiciones como inhibidores de quinasa | |
AR091519A1 (es) | Inhibidores pirrolopirazona de tanquirasa | |
AR095523A1 (es) | Derivados piridin-4-ilo | |
CR20150418A (es) | Compuestos de tetrahidropirrolotiazina | |
AR099376A1 (es) | Compuestos de diaminopirimidilo sustituidos, sus composiciones y métodos de tratamiento con aquellos | |
TR201900050T4 (tr) | Kaynaştırılmış heterosiklik bileşik ve bunun haşere kontrol uygulaması. | |
AR094812A1 (es) | Derivado de piridina monocíclico como inhibidor del fgfr | |
SA515361086B1 (ar) | Fasn مركبات وتركيبات جديدة لتثبيط | |
ES2721031T3 (es) | Compuestos de dihidroisoquinolinona sustituidos | |
RS54730B1 (sr) | Inhibitori beta sekretaze | |
AR098522A1 (es) | Compuesto de triazolo-piridina | |
RS54183B1 (en) | PIRAZOLE DERIVATIVES | |
AR101359A1 (es) | Derivados de 2-oxa-5-azabiciclo[2.2.1]heptan-3-ilo | |
AR097866A1 (es) | Derivados de 4-azaindol | |
EA201690072A1 (ru) | Состав, содержащий гиполипидемическое средство | |
AR090474A1 (es) | Compuestos de tetrahidropirrolotiazina | |
AR091770A1 (es) | Indolcarbonitrilos moduladores selectivos de receptores androgenicos | |
AR101132A1 (es) | Derivados de pirazina agonistas del gpr40 para el tratamiento de la diabetes tipo ii | |
AR100439A1 (es) | Derivados de carboxamida | |
AR095097A1 (es) | Compuestos de fenoxietoxi | |
EA201591915A1 (ru) | Соединения феноксиэтил дигидро-1h-изохинолина | |
AR097253A1 (es) | Derivado de pirazolilpirazol sustituido y el uso del mismo como herbicida | |
AR098965A1 (es) | Derivados de sulfonamidas tricíclicas | |
AR105821A1 (es) | COMPUESTOS ÚTILES PARA INHIBIR ROR-g-T |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |